Enhancing Flucytosine Anticandidal Activity Using PEGylated Squalene Nanocarrier [PDF]
Bogdan Florin Craciun +3 more
openalex +1 more source
Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa [PDF]
Jacqui Miot +4 more
openalex +1 more source
Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
Françoise Dromer +4 more
openalex +2 more sources
In Vitro Activities at pH 5.0 and pH 7.0 and In Vivo Efficacy of Flucytosine against Aspergillus fumigatus [PDF]
Paul E. Verweij +4 more
openalex +1 more source
Constrictive Pericarditis Due to Cryptococcus Neoformans in an Elderly Immunosuppressed Patient. [PDF]
Silva CP +3 more
europepmc +1 more source
Evaluation of the VITEK 2 system to test the susceptibility ofCandidaspp.,Trichosporon asahiiandCryptococcus neoformansto amphotericin B, flucytosine, fluconazole and voriconazole: a comparison with the M27-A3 reference method [PDF]
MA Trinidad González Cejudo +7 more
openalex +1 more source
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† †This study was presented, in part, at the 37th ICAAC in Toronto, Canada, 28th September – 1st October 1997. [PDF]
Caroline B. Moore +2 more
openalex +1 more source

